Peter Johansson
Peter Johansson
Verified email at
Cited by
Cited by
Whole-genome landscapes of major melanoma subtypes
NK Hayward, JS Wilmott, N Waddell, PA Johansson, MA Field, K Nones, ...
Nature 545 (7653), 175-180, 2017
Pan-cancer analysis of whole genomes
I The, TPCA of Whole, Genomes Consortium
Nature 578 (7793), 82, 2020
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
LH Saal, P Johansson, K Holm, SK Gruvberger-Saal, QB She, M Maurer, ...
Proceedings of the National Academy of Sciences 104 (18), 7564-7569, 2007
POT1 loss-of-function variants predispose to familial melanoma
CD Robles-Espinoza, M Harland, AJ Ramsay, LG Aoude, V Quesada, ...
Nature genetics 46 (5), 478-481, 2014
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
GV Long, C Fung, AM Menzies, GM Pupo, MS Carlino, J Hyman, ...
Nature communications 5 (1), 1-9, 2014
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.
P Johansson, LG Aoude, K Wadt, WJ Glasson, SK Warrier, AW Hewitt, ...
Oncotarget 7 (4), 4624-4631, 2016
Microarray expression profiling in melanoma reveals a BRAF mutation signature
S Pavey, P Johansson, L Packer, J Taylor, M Stark, PM Pollock, ...
Oncogene 23 (23), 4060-4067, 2004
Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma
LG Aoude, AL Pritchard, CD Robles-Espinoza, K Wadt, M Harland, J Choi, ...
Journal of the National Cancer Institute 107 (2), dju408, 2015
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
F Newell, Y Kong, JS Wilmott, PA Johansson, PM Ferguson, C Cui, Z Li, ...
Nature communications 10 (1), 1-15, 2019
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ...
JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018
Recurrent inactivating RASA2 mutations in melanoma
R Arafeh, N Qutob, R Emmanuel, A Keren-Paz, J Madore, A Elkahloun, ...
Nature genetics 47 (12), 1408-1410, 2015
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma
KAW Wadt, LG Aoude, P Johansson, A Solinas, A Pritchard, O Crainic, ...
Clinical genetics 88 (3), 267-272, 2015
Confirmation of a BRAF mutation‐associated gene expression signature in melanoma
P Johansson, S Pavey, N Hayward
Pigment Cell & Melanoma Research 20 (3), 216-221, 2007
Detection and identification of protein isoforms using cluster analysis of MALDI-MS mass spectra
R Alm, P Johansson, K Hjernø, C Emanuelsson, M Ringner, J Häkkinen
Journal of proteome research 5 (4), 785-792, 2006
Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN
L Packer, S Pavey, A Parker, M Stark, P Johansson, B Clarke, P Pollock, ...
Carcinogenesis 27 (9), 1778-1786, 2006
POLE mutations in families predisposed to cutaneous melanoma
LG Aoude, E Heitzer, P Johansson, M Gartside, K Wadt, AL Pritchard, ...
Familial Cancer 14 (4), 621-628, 2015
Melanomas of unknown primary have a mutation profile consistent with cutaneous sun‐exposed melanoma
K Dutton‐Regester, H Kakavand, LG Aoude, MS Stark, MG Gartside, ...
Pigment cell & melanoma research 26 (6), 852-860, 2013
microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies
JS Wei, P Johansson, QR Chen, YK Song, S Durinck, X Wen, ATC Cheuk, ...
Clinical Cancer Research 15 (17), 5560-5568, 2009
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
PA Johansson, K Brooks, F Newell, JM Palmer, JS Wilmott, AL Pritchard, ...
Nature Communications 11 (1), 1-8, 2020
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
F Newell, JS Wilmott, PA Johansson, K Nones, V Addala, ...
Nature communications 11 (1), 1-14, 2020
The system can't perform the operation now. Try again later.
Articles 1–20